Hospital-Acquired Pneumonia Definition and Diagnosis

Key Diagnostic Criteria

Hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs 48 hours or more after hospital admission, which was not incubating at the time of admission, according to the American Thoracic Society 1, 2, 3
HAP is characterized by new or progressive lung infiltrates on chest radiography, clinical evidence of infectious origin, including fever, leukocytosis or leukopenia, and at least two of the following: purulent sputum, cough or dyspnea, declining oxygenation or increased oxygen requirement 4

Non-ventilator HAP occurs after 48 hours of hospital stay in non-ventilated patients, as defined by the American College of Chest Physicians 5, 4
Ventilator-associated pneumonia (VAP) develops in ICU patients who have been mechanically ventilated for at least 48 hours, according to the European Respiratory Society 2, 3

HAP is the second most common nosocomial infection after bloodstream infections, and the most common infection acquired in intensive care units, resulting in significant morbidity and mortality 6, 2
The incidence of HAP ranges from 5 to more than 20 cases per 1000 hospital admissions, and is associated with increased duration of mechanical ventilation, ICU stay, and hospital length of stay 2, 5
HAP significantly increases healthcare costs, with estimates ranging from $10,000 to $40,000 per case, as reported by the European Respiratory Society 2

Early-onset HAP is usually caused by community-acquired pathogens, including methicillin-susceptible Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae 1, 6, 4
Late-onset HAP is more likely to involve multidrug-resistant organisms, such as Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus 4, 1

Microbiological confirmation is crucial for definitive diagnosis, based on qualitative or quantitative cultures of respiratory samples, with pathogens identified in approximately 70% of suspected cases, as recommended by the American College of Chest Physicians 4

By definition, HAP is not present or incubating at the time of hospital admission, and ventilator-associated pneumonia (VAP) develops in ICU patients who have been mechanically ventilated for at least 48 hours 7
Early-onset HAP occurs within the first 5 days of hospitalization, and late-onset HAP occurs after 5 days of hospitalization 8

Duration of ICU or hospital stay, particularly prolonged stays over 5 days, previous antibiotic use, and previous colonization with multidrug-resistant pathogens are risk factors for HAP 8
For patients with risk factors for multidrug-resistant pathogens, broader spectrum antibiotics may be necessary 8
A 7-8 day course of antibiotics is recommended for most patients with HAP/VAP who have a good clinical response to therapy 9

The mortality rate associated with HAP is approximately 20%, with attributable mortality estimated between 5-13% 10

The American Thoracic Society guidelines recommend that hospital-acquired pneumonia diagnosis requires clinical and radiographic criteria, not specific A-a gradient values, and arterial oxygenation should be measured to determine supplemental oxygen needs and assess for respiratory acidosis 11
Arterial blood gas analysis helps define severity of illness and presence of multiple organ dysfunction, according to the American Thoracic Society 11
Serial measurements of A-a gradient help track clinical response to therapy, as suggested by the American Thoracic Society 11
The American Thoracic Society guidelines emphasize that the diagnosis of hospital-acquired pneumonia requires comprehensive clinical, radiographic, and microbiological criteria, and the A-a gradient should not be relied upon alone for diagnosis or exclusion 12, 11

Non‑ventilator hospital‑acquired pneumonia (HAP) occurs in patients who are not on mechanical ventilation after ≥48 hours of hospital stay and can arise on general wards or in intensive‑care units; its incidence is approximately 1.6 % of all admissions (≈3.63 cases per 1,000 patient‑days)【13】.
Ventilator‑associated pneumonia (VAP) develops in patients who have been mechanically ventilated for ≥48 hours after intubation; incidence ranges from 1.9–3.8 per 1,000 ventilator‑days in the United States and exceeds 18 per 1,000 ventilator‑days in Europe【13】.
The key distinction is that VAP timing is measured from the start of mechanical ventilation, whereas non‑ventilator HAP timing is measured from hospital admission【13】.

The overall mortality associated with hospital‑acquired pneumonia is roughly 20 %【13】.
Mortality directly attributable to the pneumonia itself (attributable mortality) is estimated at 5–13 %【13】.